These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35311607)

  • 1. Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice.
    Mao R; Yang M; Yang R; Chen Y; Diao E; Zhang T; Li D; Chang X; Chi Z; Wang Y
    Drug Deliv; 2022 Dec; 29(1):925-936. PubMed ID: 35311607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD mice.
    Mao R; Wang J; Xu Y; Wang Y; Wu M; Mao L; Chen Y; Li D; Zhang T; Diao E; Chi Z; Wang Y; Chang X
    Drug Deliv; 2023 Dec; 30(1):2173339. PubMed ID: 36719009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of single-chain insulin (SCI-59) analog by bacterium-like particles (BLPs) induces oral tolerance and prevents autoimmune diabetes in NOD mice.
    Mao R; Chen Y; Wu Q; Zhang T; Diao E; Wu D; Wang M; Liu Y; Lu L; Chang X; Zheng Y; Wang Y
    Immunol Lett; 2019 Oct; 214():37-44. PubMed ID: 31473255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants.
    Mett V; Shamloul AM; Hirai H; Zhou Z; Notkins A; Yusibov V
    Transgenic Res; 2007 Feb; 16(1):77-84. PubMed ID: 17103024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application.
    Guerra LL; Faccinetti NI; Trabucchi A; Rovitto BD; Sabljic AV; Poskus E; Iacono RF; Valdez SN
    BMC Biotechnol; 2016 Nov; 16(1):84. PubMed ID: 27881117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice.
    Chen Y; Wu J; Wang J; Zhang W; Xu B; Xu X; Zong L
    Diabetologia; 2018 Jun; 61(6):1384-1396. PubMed ID: 29546475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.
    Liu KF; Liu XR; Li GL; Lu SP; Jin L; Wu J
    Immunol Lett; 2016 Jun; 174():28-36. PubMed ID: 27085380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-yield expression of properly folded insulinoma-associated protein intracellular domain (IA-2ic) in Escherichia coli.
    Sica MP; Primo ME; Ermácora MR; Poskus E
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):301-9. PubMed ID: 12515576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
    Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
    Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients.
    Medici F; Hawa MI; Giorgini A; Panelo A; Solfelix CM; Leslie RD; Pozzilli P
    Diabetes Care; 1999 Sep; 22(9):1458-61. PubMed ID: 10480509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse.
    Koczwara K; Schenker M; Schmid S; Kredel K; Ziegler AG; Bonifacio E
    Clin Immunol; 2003 Feb; 106(2):155-62. PubMed ID: 12672406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
    Liu B; Yue Y; Yang Y; Jin Y
    PLoS One; 2016; 11(1):e0147260. PubMed ID: 26783749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes.
    Morran MP; Casu A; Arena VC; Pietropaolo S; Zhang YJ; Satin LS; Nelson P; Omenn GS; Trucco M; Becker DJ; Pietropaolo M
    Endocrinology; 2010 Jun; 151(6):2528-37. PubMed ID: 20382696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes.
    Morgenthaler NG; Löbner K; Morgenthaler UY; Christie MR; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Sep; 30(9):559-64. PubMed ID: 9808324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay.
    Westerlund-Karlsson A; Suonpää K; Ankelo M; Ilonen J; Knip M; Hinkkanen AE
    Clin Chem; 2003 Jun; 49(6 Pt 1):916-23. PubMed ID: 12765988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjuvant effect of bacterium-like particles depends on the route of administration.
    Sudo H; Tokunoh N; Tsujii A; Kawashima S; Hayakawa Y; Fukushima H; Takahashi K; Koshizuka T; Inoue N
    Front Immunol; 2023; 14():1082273. PubMed ID: 36742329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.